Stem Cell Research under the Microscope at Arab Health

Published January 29th, 2007 - 07:47 GMT
Al Bawaba
Al Bawaba

The latest developments in stem cell research are being discussed this week, held as part of the Congress Sessions of Arab Health 2007, the region’s largest medical exhibition and congress series.

Developments in the field of stem cell treatments are followed with interest by the Middle East medical community, especially since such transplants have been successful in the treatment of thalassemia – the inherited blood disorder which is particularly prevalent in the region.

Internationally-renowned Dr. Susan Lim of the Gleneagles Medical Centre, Singapore, will deliver a lecture on the topic of the use of stem cells in regenerative medicine and tissue repair, drawing on the experience of Gleneagles as the first centre to launch a stem cell transplantation program, and whose physicians were among the first to perform stem cell transplants.

Dr. Lim will be joined by a number of leading Singaporean physicians, who will lead sessions on a range of advanced medical treatments, including a laparoscopic approach to treating cancer and the latest developments in breast MRI screening and biopsy.

Dr. Jee Lim Tan and Dr. Chris Chong also of Gleneagles Hospital and Dr. Sim Shao-Jen from Singapore General Hospital will be among other physicians participating in the lecture series.

“Our aim in bringing such a distinguished panel to Dubai is to foster greater knowledge-sharing between healthcare bodies from Singapore and the Middle East and also to share some of the major medical advances being made in our country,” said Ke-Wei Peh, Area Director for the Middle East and Africa, Singapore Tourism Board.

Singapore has one of Asia’s most advanced medical systems and has invested significantly in revolutionary treatment areas, such as robotic surgery and living donor liver transplants.

Arab Health runs from 29 January until 1 February 2007.

 

About SingaporeMedicine
SingaporeMedicine is a multi-agency government-industry partnership to develop and promote Singapore as a medical hub. In 2005, 374,000 international patients came to Singapore specifically for healthcare, and many more sought her quality healthcare on trips for other purposes. In 2000, the World Health Organization ranked Singapore as having the best healthcare system in Asia, with excellent healthcare outcomes for her people while maintaining affordability. With one third of all Joint Commission International (JCI) accredited facilities in Asia, Singapore offers internationally trained and respected healthcare professionals, advanced technology and the latest and safest drugs, backed by a sound research foundation, for better diagnostics and outcomes. International patient liaison services, a cosmopolitan culture, convenient access and transport, and a clean and safe environment provide peace of mind to healthcare visitors and their families in their time of need. For more information, visit www.singaporemedicine.com.